Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
10x Genomics, Inc. (NASDAQ: TXG)
TXG Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
3%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-28.90%
TXG Stock Analysis
TXG
PE Ratio:
TXG
PEG Ratio:
Not Available
TXG
Forward EPS Growth (12 month):
0.00%
TXG
PS Ratio:
6.4
TXG
PSG Ratio:
0.7
TXG
Forward Revenue Growth (12 month):
8.80%
TXG Articles
Hugh Pambrun |
March 24, 2026
Cathie Wood Just bought $1.8M of This Stock
TXG
